GE Healthcare is collaborating on the construction of a center for advanced therapeutic cell technologies in Toronto.
The company has joined the Canadian Federal Economic Development Agency for Southern Ontario (FedDev Ontario) and the Centre for Commercialization of Regenerative Medicine (CCRM) in the project.
GE and FedDev Ontario will invest $40 million Canadian ($36 million U.S.) in the project, while GE and CCRM partner with pharma, biotech, and cell therapy companies to advance the initiative.
The center's objective will be to accelerate the development and adoption of cell manufacturing technologies to improve patient access to novel regenerative medicine-based therapies.
The facility will also provide cell therapy companies with resources and expertise to help establish manufacturing processes that can produce the large cell numbers required for clinical and commercial use.
